|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Walboomers JM, Jacobs MV, Manos MM, Bosch
FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hausen Zur H: Papillomaviruses and cancer:
From basic studies to clinical application. Nat Rev Cancer.
2:342–350. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Scheffner M, Huibregtse JM, Vierstra RD
and Howley PM: The HPV-16 E6 and E6-AP complex functions as a
ubiquitin-protein ligase in the ubiquitination of p53. Cell.
75:495–505. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Scheffner M, Werness BA, Huibregtse JM,
Levine AJ and Howley PM: The E6 oncoprotein encoded by human
papillomavirus types 16 and 18 promotes the degradation of p53.
Cell. 63:1129–1136. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang H, Mo P, Ren S and Yan C: Activating
transcription factor 3 activates p53 by preventing E6-associated
protein from binding to E6. J Biol Chem. 285:13201–13210. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen JJ, Reid CE, Band V and Androphy EJ:
Interaction of papillomavirus E6 oncoproteins with a putative
calcium-binding protein. Science. 269:529–531. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee SS, Weiss RS and Javier RT: Binding of
human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the
Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci
USA. 94:6670–6675. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ronco LV, Karpova AY, Vidal M and Howley
PM: Human papillomavirus 16 E6 oncoprotein binds to interferon
regulatory factor-3 and inhibits its transcriptional activity.
Genes Dev. 12:2061–2072. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Underbrink MP, Howie HL, Galloway DA,
Bedard KM and Koop JI: E6 proteins from multiple human
betapapillomavirus types degrade Bak and protect keratinocytes from
apoptosis after UVB irradiation. J Virol. 82:10408–10417. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao Q, Srinivasan S, Boyer SN, Wazer DE
and Band V: The E6 oncoproteins of high-risk papillomaviruses bind
to a novel putative GAP protein, E6TP1 and target it for
degradation. Mol Cell Biol. 19:733–744. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu X, Dakic A, Zhang Y, Dai Y, Chen R and
Schlegel R: HPV E6 protein interacts physically and functionally
with the cellular telomerase complex. Proc Natl Acad Sci USA.
106:18780–18785. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hengstermann A, Linares LK, Ciechanover A,
Whitaker NJ and Scheffner M: Complete switch from Mdm2 to human
papillomavirus E6-mediated degradation of p53 in cervical cancer
cells. Proc Natl Acad Sci USA. 98:1218–1223. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bischoff JR and Plowman GD: The
Aurora/Ipl1p kinase family: Regulators of chromosome segregation
and cytokinesis. Trends Cell Biol. 9:454–459. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW,
Sahin A, Brinkley BR and Sen S: Tumour amplified kinase STK15/BTAK
induces centrosome amplification, aneuploidy and transformation.
Nat Genet. 20:189–193. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gautschi O, Heighway J, Mack PC, Purnell
PR, Lara PN and Gandara DR: Aurora kinases as anticancer drug
targets. Clin Cancer Res. 14:1639–1648. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Giovinazzi S, Morozov VM, Summers MK,
Reinhold WC and Ishov AM: USP7 and Daxx regulate mitosis
progression and taxane sensitivity by affecting stability of
Aurora-A kinase. Cell Death Differ. 20:721–731. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang H, He L, Kruk P, Nicosia SV and Cheng
JQ: Aurora-A induces cell survival and chemoresistance by
activation of Akt through a p53-dependent manner in ovarian cancer
cells. Int J Cancer. 119:2304–2312. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu Q, Kaneko S, Yang L, Feldman RI,
Nicosia SV, Chen J and Cheng JQ: Aurora-A abrogation of p53 DNA
binding and transactivation activity by phosphorylation of serine
215. J Biol Chem. 279:52175–52182. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Katayama H, Sasai K, Kawai H, Yuan ZM,
Bondaruk J, Suzuki F, Fujii S, Arlinghaus RB, Czerniak BA and Sen
S: Phosphorylation by aurora kinase A induces Mdm2-mediated
destabilization and inhibition of p53. Nat Genet. 36:55–62. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chien CY, Tsai HT, Su LJ, Chuang HC, Shiu
LY, Huang CC, Fang FM, Yu CC, Su HT and Chen CH: Aurora-A signaling
is activated in advanced stage of squamous cell carcinoma of head
and neck cancer and requires osteopontin to stimulate invasive
behavior. Oncotarget. 5:2243–2262. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meraldi P, Honda R and Nigg EA: Aurora-A
overexpression reveals tetraploidization as a major route to
centrosome amplification in p53−/− cells. EMBO J.
21:483–492. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo Y, Meng XK, Wang Q, Wang Y and Shang
H: The ING4 binding with p53 and induced p53 acetylation were
attenuated by human papillomavirus 16 E6. PLoS One. 8:e714532013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCq method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu X, Li Z, Song Y, Wang R, Han L, Wang
Q, Jiang K, Kang C and Zhang Q: AURKA induces EMT by regulating
histone modification through Wnt/β-catenin and PI3K/Akt signaling
pathway in gastric cancer. Oncotarget. 21:April 21–2016.(Epub ahead
of print).
|
|
26
|
Li Z, Sun Y, Chen X, Squires J,
Nowroozizadeh B, Liang C and Huang J: p53 mutation directs AURKA
overexpression via miR-25 and FBXW7 in prostatic small cell
neuroendocrine carcinoma. Mol Cancer Res. 13:584–591. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tanaka M, Ueda A, Kanamori H, Ideguchi H,
Yang J, Kitajima S and Ishigatsubo Y: Cell-cycle-dependent
regulation of human aurora A transcription is mediated by periodic
repression of E4TF1. J Biol Chem. 277:10719–10726. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Marumoto T, Zhang D and Saya H: Aurora-A -
a guardian of poles. Nat Rev Cancer. 5:42–50. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Warner SL, Bearss DJ, Han H and Von Hoff
DD: Targeting Aurora-2 kinase in cancer. Mol Cancer Ther.
2:589–595. 2003.PubMed/NCBI
|
|
30
|
Carmena M and Earnshaw WC: The cellular
geography of Aurora kinases. Nat Rev Mol Cell Biol. 4:842–854.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kimura M, Matsuda Y, Yoshioka T and Okano
Y: Cell cycle-dependent expression and centrosome localization of a
third human Aurora/IpI1-related protein kinase, AIK3. J Biol Chem.
274:7334–7340. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kimura M, Kotani S, Hattori T, Sumi N,
Yoshioka T, Todokoro K and Okano Y: Cell cycle-dependent expression
and spindle pole localization of a novel human protein kinase, Aik,
related to aurora of Drosophila and yeast Ipl1. J Biol Chem.
272:13766–13771. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Marumoto T, Honda S, Hara T, Nitta M,
Hirota T, Kohmura E and Saya H: Aurora-a kinase maintains the
fidelity of early and late mitotic events in HeLa cells. J Biol
Chem. 278:51786–51795. 2003. View Article : Google Scholar : PubMed/NCBI
|
